August 29, 2025

Fortrea Holdings Inc. (FTRE) Stock Analysis: Navigating a 52-Week Volatile Range with Strategic Insights

Fortrea Holdings Inc. (FTRE), a compelling player in the Biotechnology sector, operates within the Healthcare industry and is headquartered in Durham, North Carolina. Specializing as a contract research organization, Fortrea..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a Potential 187.93% Upside in the Biotechnology Sector

Sana Biotechnology, Inc. (SANA), a pioneering force in the biotechnology sector, has attracted significant investor interest due to its ambitious approach to utilizing engineered cells as medicines. With a focus..

Dianthus Therapeutics, Inc. (DNTH) Stock Analysis: A Biotech Gem with Over 111% Upside Potential

Dianthus Therapeutics, Inc. (NASDAQ: DNTH), a clinical-stage biotechnology company, is making waves in the healthcare sector due to its innovative approach to treating severe autoimmune and inflammatory diseases. With a..

GH Research PLC (GHRS) Stock Analysis: A Bold Biotech Bet with 137% Upside Potential

GH Research PLC (NASDAQ: GHRS) is attracting considerable attention in the biotechnology sector, with a striking potential upside of 137.15% according to analysts. This Dublin-based clinical-stage biopharmaceutical company is pioneering..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Exploring a Potential 211.75% Upside for Investors

Tectonic Therapeutic, Inc. (NASDAQ: TECX), a promising name in the biotechnology sector, is drawing significant attention from investors with a remarkable potential upside of 211.75%. Specializing in the discovery and..

Vir Biotechnology, Inc. (VIR) Stock Analysis: Unpacking a 254.66% Potential Upside in the Biotech Sector

Vir Biotechnology, Inc. (NASDAQ: VIR) stands out in the biotechnology sector with an impressive potential upside of 254.66%, according to analyst ratings. This San Francisco-based clinical-stage biopharmaceutical company specializes in..

Definitive Healthcare Corp. (DH) Stock Analysis: Unveiling a 13.15% Potential Upside

Definitive Healthcare Corp. (NASDAQ: DH), a key player in the healthcare information services industry, is catching the attention of investors with its substantial potential upside of 13.15%. With a current..

Savara, Inc. (SVRA) Stock Analysis: Exploring a Remarkable 155% Upside Potential in the Biotech Sector

For investors hunting for promising opportunities in the biotechnology sector, Savara, Inc. (NASDAQ: SVRA) presents a compelling case with its significant potential upside. With a market capitalization of $565.18 million,..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: Exploring a 75% Potential Upside in the Biotech Arena

Maze Therapeutics, Inc. (NASDAQ: MAZE) is making significant waves in the biotechnology sector, promising investors substantial growth opportunities. With its focus on developing precision medicines, Maze is carving out a..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Challenges with a 30% Revenue Growth

Sonida Senior Living, Inc. (SNDA), a key player in the healthcare sector, specifically within the medical care facilities industry, operates senior housing communities across the United States. With a market..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: Biotechnology Innovator with a 255% Potential Upside

Relay Therapeutics, Inc. (NASDAQ: RLAY) is making waves in the healthcare sector, specifically within the biotechnology industry. Based in Cambridge, Massachusetts, Relay Therapeutics is a clinical-stage precision medicines company focused..

Claritev Corporation (CTEV) Stock Analysis: Navigating the Ups and Downs of a Promising Healthcare Player

Claritev Corporation (NASDAQ: CTEV) has emerged as a notable player in the healthcare sector, specializing in health information services. With a market capitalization of $1.17 billion, Claritev operates primarily in..

Immatics N.V. (IMTX) Stock Analysis: A Promising Biotech with 158% Potential Upside

Immatics N.V. (NASDAQ: IMTX), a clinical-stage biopharmaceutical company based in Germany, has been gaining attention in the investment community for its innovative approach to cancer treatment. The company specializes in..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Navigating Diagnostic Innovations Amidst Market Volatility

Myriad Genetics, Inc. (NASDAQ: MYGN) stands as a pivotal player in the healthcare sector, specifically within the diagnostics and research industry. With a market cap of approximately $578.74 million, the..

Precigen, Inc. (PGEN) Stock Analysis: Unraveling an 81% Upside Potential in Biotechnology

Investors keen on the biotechnology sector should pay close attention to Precigen, Inc. (NASDAQ: PGEN), a discovery and clinical-stage biopharmaceutical company with a market capitalization of $1.36 billion. Specializing in..

Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: Exploring a Remarkable 244.58% Potential Upside

Cullinan Therapeutics, Inc. (NASDAQ: CGEM) stands out in the biotechnology industry with a compelling investment narrative, particularly for those following the healthcare sector. With a market capitalization of $449.56 million,..

Bicycle Therapeutics (BCYC) Stock Analysis: Unpacking a 237.7% Potential Upside in Biotech

Bicycle Therapeutics plc (NASDAQ: BCYC), a pioneering entity in the biotechnology sector, has captured investor attention with a staggering potential upside of 237.7%. This UK-based clinical-stage pharmaceutical company is at..

Owens & Minor, Inc. (OMI) Stock Analysis: Navigating Challenges with a 23% Upside Potential

Owens & Minor, Inc. (NYSE: OMI), a stalwart in the healthcare sector, operates as a comprehensive healthcare solutions provider, catering to a broad array of medical distribution needs. With its..

REGENXBIO Inc. (RGNX) Stock Analysis: Unpacking a 230% Potential Upside in Biotech Innovations

Investors in the biotechnology sector are keeping a keen eye on REGENXBIO Inc. (NASDAQ: RGNX), a clinical-stage biotech firm that’s making waves with its promising pipeline of gene therapies. The..

Search

Funds

August 29, 2025

Search

Funds

August 29, 2025

FTSE 100

Funds